In vitro maturation rates in young premenarche patients
Article In Press
Gilad Karavani, M.D., Natali Schachter-Safrai, M.D., Ariel Revel, M.D., Talya Mordechai-Daniel, Ph.D., Dvora Bauman, M.D., Tal Imbar, M.D.
To evaluate in vitro maturation (IVM) efficacy and oocyte retrieval rates after ovarian tissue cryopreservation in young premenarche girls facing chemo- and radiotherapy.
A retrospective cohort study.
University-affiliated tertiary medical center.
A total of 84 chemotherapy-naïve patients ages 0–18 years referred for fertility preservation between 2004 and 2017: 33 premenarche and 51 postmenarche patients.
Main Outcome Measure(s)
IVM in the pre- and postmenarche groups and in the subgroups of very young (up to age 5 years) and older (5–10 years) premenarche girls.
The number of oocytes retrieved did not significantly differ between the postmenarche and premenarche groups (10.8 ± 8.5 and 8.1 ± 6.8, respectively). However, the overall IVM rate was significantly higher in the postmenarche group (28.2% vs. 15.5%, respectively; odds ratio = 0.47). A separate analysis for patients up to 5 years of age demonstrated significantly lower oocyte yield compared with the older (5–10 years) premenarche girls (4.7 ± 5.2 vs.10.3 ± 7.0 oocytes, respectively) and much lower IVM rates (4.9% and 18.2%, respectively). Correlation of age with number of retrieved and matured oocytes showed a positive significant correlation (r = 0.45 and r = 0.64, respectively).
IVM performed after ovarian tissue cryopreservation in premenarche girls and specifically in very young girls (4 years and younger) yields substantially decreased maturation rates compared with postmenarche patients, raising a question as to the utility of current IVM technique in this age group. Further studies are required to assess modification of the IVM technique for young girls.